In 2010 Jason Hope, a well-known entrepreneur, futurist, philanthropist, and technologists donated $500,000 to SENs research Foundation. His donation was geared towards constructing the Cambridge SENs Laboratory as well as starting a new research program. In a statement after the contribution, Jason Hope indicated that he was privileged to have contributed towards the organization’s anti-aging research. He said that the donation would help cure degenerative diseases that make people age unnecessarily fast. He gave examples of lung diseases and Alzheimer’s disease saying that these disorders not only affect the lung and the brain respectively but also lead to premature aging.
— Jason Hope (@JasonHope) April 12, 2016
AGE Breaker Program
With the donation, SENs foundation has developed AGE-breaker program. This marks a significant milestone as a drug has to be able to break down advanced glycation end (AGE) for it to qualify being called AGE-breaker. AGE is a metabolic waste that fastens degenerative process in the body. It is tied to age-related diseases such as osteoporosis, Parkinson’s, arthritis and Alzheimer’s. AGE leads to loss of elasticity of blood vessels and skin in aged people. These diseases are referred to as age-related as they are caused by the degenerative action of the body cells that happen at old age. Since there has been little research on these disorders, the Scottsdale, Arizona-based philanthropist felt that it is a sector worth investing.
Over the last few decades, AGE-breaking studies and treatments have failed. This failure has been attributed to the use of animals in the lab expecting the results to be replicated in human beings. Results in human have been very different to results in animals as the latter is short-lived. Additionally, animals and humans have distinct genetic makeup, and thus results cannot be easily replicated in humans.
Today, researchers have understood the difference between human and animal experiments and found glucosepane, a protein in human AGE that is thought to be a significant breakthrough. With the discovery of this protein, Jason Hope will go down in history as one of the philanthropists who donated towards this great invention. With this finding, researchers are expected to eliminate the AGEs that are present in degenerative diseases, consequently increasing the lifespan of people suffering from degenerative disorders.
About Jason Hope
Jason Hope is an investor, futurist, philanthropist and entrepreneur based in Scottsdale, Arizona. He is globally known for his passion towards charitable activities and technology. Hope holds a degree in finance from the Arizona State University. He also holds an MBA from the Arizona State University’s W.P. Carey School of Business. Hope is a great believer of the Internet of Things (IoT).
Jason Hope Info: www.facebook.com/jason.r.hope